Hepatic ablation of SIRT6 results in fatty liver disease, yet the potential mechanism of SIRT6 deficiency, particularly in relation to downstream mediators for NAFLD, remains elusive. This evidence concerns the gene SIRT6 and metabolic dysfunction-associated steatotic liver disease.